These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 9667244)

  • 1. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of cancer patients and their physicians involved in phase I trials.
    Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
    J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.
    Daugherty CK
    J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 1 oncology trials and informed consent.
    Miller FG; Joffe S
    J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial on the ethics of phase I trials.
    Emanuel EJ
    J Clin Oncol; 1995 May; 13(5):1049-51. PubMed ID: 7738609
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I cancer trials. A collusion of misunderstanding.
    Miller M
    Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.
    Tomamichel M; Sessa C; Herzig S; de Jong J; Pagani O; Willems Y; Cavalli F
    Ann Oncol; 1995 Apr; 6(4):363-9. PubMed ID: 7619751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed consent in psychiatric research: preliminary findings from an ongoing investigation.
    Benson PR; Roth LH; Winslade WJ
    Soc Sci Med; 1985; 20(12):1331-41. PubMed ID: 2862705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
    Kodish E; Stocking C; Ratain MJ; Kohrman A; Siegler M
    J Clin Oncol; 1992 Nov; 10(11):1810-6. PubMed ID: 1403062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
    Ratain MJ; Mick R; Schilsky RL; Siegler M
    J Natl Cancer Inst; 1993 Oct; 85(20):1637-43. PubMed ID: 8411243
    [No Abstract]   [Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting meaningful informed consent from older adults: a structured literature review of empirical research.
    Sugarman J; McCrory DC; Hubal RC
    J Am Geriatr Soc; 1998 Apr; 46(4):517-24. PubMed ID: 9560079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research with Alzheimer's disease subjects: informed consent and proxy decision making.
    High DM
    J Am Geriatr Soc; 1992 Sep; 40(9):950-7. PubMed ID: 1512393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues in the development of new agents.
    Daugherty CK
    Invest New Drugs; 1999; 17(2):145-53. PubMed ID: 10638485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical and practical problems of early anti-cancer drug trials: a review of the literature.
    Cox K; Avis M
    Eur J Cancer Care (Engl); 1996 Jun; 5(2):90-5. PubMed ID: 8716204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine.
    Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA
    Patient Educ Couns; 1994 Dec; 24(3):261-6. PubMed ID: 7753719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed Consent among Clinical Trial Participants with Different Cancer Diagnoses.
    Ulrich CM; Ratcliffe SJ; Hochheimer CJ; Zhou Q; Huang L; Gordon T; Knafl K; Richmond T; Schapira MM; Miller V; Mao JJ; Naylor M; Grady C
    AJOB Empir Bioeth; 2024; 15(3):165-177. PubMed ID: 37921867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The elderly patient and informed consent. Empirical findings.
    Stanley B; Guido J; Stanley M; Shortell D
    JAMA; 1984 Sep; 252(10):1302-6. PubMed ID: 6471248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical issues associated with conducting genetic family studies of complex disease.
    Arar NH; Hazuda H; Steinbach R; Arar MY; Abboud HE
    Ann Epidemiol; 2005 Oct; 15(9):712-9. PubMed ID: 16157258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.